Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Stanford University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
University of Rochester
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indiana University
Northside Hospital, Inc.
Northside Hospital, Inc.